Results 11 to 20 of about 23,559,862 (313)
Cetuximab and biomarkers in non-small-cell lung carcinoma
Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer ...
Patil N, Abba M, Allgayer H
doaj +6 more sources
Background : Lung cancer is the leading cause of cancer-related mortality over worldwide. Although the pathological diagnosis of lung carcinoma is limited as only small specimen available for diagnosis, the availability of targeted therapies has
Mayank Agrawal +4 more
doaj +1 more source
The Significance of BRCA-associated Protein (BAP1) and Calretinin Expression in Malignant Pleural Mesothelioma and Non-small Cell Lung Carcinoma: An Immunohistochemical Study [PDF]
Background: Malignant pleural mesothelioma (MPM) and non-small cell lung carcinoma (NSCLC) are common diseases with rising incidence, patients have different prognosis and are treated differently, and thus it is very important to diagnose these ...
Amira Salem +3 more
doaj +1 more source
the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma
Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet +3 more
doaj +1 more source
This is the first case described of transformation from EGFR wild-type non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) during immunotherapy presenting with severe hyponatremia due to paraneoplastic syndrome of inappropriate ...
Vicky Mai +4 more
doaj +1 more source
Combined small‐cell lung carcinoma (C‐SCLC) is small‐cell lung carcinoma (SCLC) with added non–small‐cell morphology. We report a case of epidermal growth factor receptor (EGFR) mutation‐positive C‐SCLC in an 84‐year‐old patient with metastatic brain ...
Yu‐Chung Li
doaj +1 more source
Lung: Non-small cell carcinoma [PDF]
Non-small cell carcinomas are divided into three main categories according to the predominant morphology of the tumour cells as determined by light microscopy. Although it is possible to distinguish different histological sub-groups in this way, or by using gene expression profiling, treatment is currently decided on the basis of tumour staging, age ...
J Heighway, DC Betticher
openaire +1 more source
Immune checkpoint inhibitors with chemotherapy have been shown to exhibit remarkable efficacy for advanced non‐small‐cell lung carcinoma and are under investigation as an induction therapy.
Shunichi Saito +6 more
doaj +1 more source
Epigenetics in non-small cell lung carcinomas
Objective. To perform a systematic review of the main epigenetic aberrations involved in non-small cell lung carcinomas’ (NSCLC) diagnosis, progression, and therapeutics. Materials and methods. We performed a systematic review of the scientific literature on lung cancer epigenetics, focusing on NSCLC. Results.
Irlanda Peralta-Arrieta +3 more
openaire +3 more sources
Non-small cell lung carcinoma metastasis to the anus [PDF]
A 70-year-old man presenting with a lung mass was investigated and treated with pneumonectomy for adenocarcinoma of the lung. He re-presented 3 months later with a large perianal abscess and mass. Subsequent investigations and biopsies showed disseminated metastases from the lung primary.
Ramya Gowri, Dhandapani +2 more
openaire +2 more sources

